NewsSource: EClinCloud

More good stories to continue in 2022—EClinCloud wishes you a Happy New Year!

3 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: eClinCloud.


HEY! 2022
◉HAPPY NEW YEAR · 2022
2021: Thank you for being with us

2022: Let's move forward together

Article image
Celebrating New Year's Day ● Welcoming the New Year
HAPPY NEW YEAR · 2022
Article image

2022 · Happy New Year's Day

A new cycle begins as the morning sun rises; a fresh year opens new horizons and embraces all possibilities.

May good things endure, and may the years always feel new.

In the new year, we wish you continued happiness and good fortune.


Article image
HAPPY NEW YEAR · 2022
THANK
YOU
●
2
0
2
1


Article image



HAPPY  NEW YEAR TO YOU


In the blink of an eye, 365 days have slipped by. In 2021, EClinCloud completed its transformation from 0 to 1, successively launching CTMS, eTMF, eCOA, resource management, and other systems, delivering extensive scale management services, and establishing an exclusive strategic partnership with Signant Health. The company continued to expand, completed Series A financing, relocated its Shenzhen and Chengdu offices, and moved into new offices in Beijing and Shanghai.


NEW YEAR

Article image
Article image

We are grateful for our clients' support and our employees' dedication this past year. As we set out again in the new year, may there be no rough waters ahead, only bright horizons!




HAPPY NEW YEAR · 2022
BEST
WISHES
●
2
0
2
2


Article image



HAPPY  NEW YEAR TO YOU


In the new year of 2022, EClinCloud will continue to launch EDC, RTSM, device logistics, and other systems, completing the build-out of the EClinCloud Clinical Evidence Support SaaS Cloud Platform to empower new drug R&D with digital and intelligent capabilities. At the same time, our back-end medical support, rater training, and endpoint assessment services for international multi-center clinical trials will continue to expand, making clinical trial endpoints more precise. In the new year, everything is renewed—it is a fresh beginning!

Article image
Article image

As 2022 arrives, we wish you every success and good fortune in all you do!




HAPPY NEW YEAR · 2022
20
22
●
HAPPY
NEW
YEAR
!


Article image



HAPPY  NEW YEAR TO YOU


In 2022, may every regret turn into an unexpected delight around the next corner. Happiness may not arrive on demand, yet it will never be absent.

Article image
Article image

Through all the ups and downs, another year has passed—goodbye 2021, hello 2022! In the new year, may every day hold promise and may happiness visit often!




Article image
Article image
2021: Saying goodbye

2022: Looking forward

HAPPY  NEW YEAR TO YOU



In the new year, may your days be like the first light of dawn—warm and serene.

In the new year, may you stay true to yourself and live earnestly.

May those you love enjoy steady joy and peace.

May all you hope for find its way to your heart.


20
22
●
HAPPY
NEW
YEAR
Joy




[About EClinCloud]

With the mission of "bringing effective treatments to patients through technological innovation," EClinCloud is a healthcare and life sciences technology company based in China and serving the world. We provide an integrated all-in-one cloud platform and clinical trial endpoint assessment technologies across therapeutic areas, building a globally leading, patient-centric SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs and devices, and benefit countless patients.







Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.